Breast Cancer Research and Treatment

, Volume 45, Issue 3, pp 263–270 | Cite as

Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial

  • Jan Frisell
  • Elisabet Lidbrink
  • Lars Hellström
  • Lars-Erik Rutqvist


Results from several randomised mammography screening trials haveshown that it is possible to reduce mortalityin breast cancer by mammographic screening at leastfor women above 50 years of age. Thepurpose of this article is to present dataon mortality in breast cancer in study andcontrol groups of the Stockholm trial after 11years of followup, to analyse which age groupbenefits most from screening. In March 1981, 40,318women in Stockholm, aged 40 through 64 years,entered a randomized trial of breast cancer screeningby single view mammography alone, versus no interventionin a control group of 20 000 women.Two screening rounds were performed and the attendancerate was over 80% in the two rounds.During 1986 the control group was invited onceto screening. Totally 428 and 217 cases ofbreast cancer were diagnosed in the study andcontrol groups respectively. After a mean follow-up of11.4 years a nonsignificant mortality reduction of 26%was observed for the whole study group, witha relative risk (RR) of death in breastcancer of 0.74 (CI(confidence interval)=0.5–1.1). Forwomen aged 50–64 years a significant 38% mortalityreduction was observed with a RR of 0.62(CI=0.38–1.0). For women aged 40–49 yearsno effect on mortality was found, with aRR of death in breast cancer of 1.08(CI=0.54–2.17). The breakpoint for benefit inthis study seemed to be at 50 yearsof age when 5-year age groups were analysed,but this tendency is uncertain because of thelow statistical power in the analysis of theyounger age groups. Long screening intervals, the useof single-view mammography, and the fact that morethan 50% of the women in age group40–49 years were still below 50 years ofage when the study was closed, were allfacts that could have influenced the results inage group 40–49 years. Larger studies are neededto answer the question whether mammographic screening canbe successful in younger age groups.

breast cancer mass mammography screening mortality 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shapiro S, Strax P, Venet L: Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 215: 1777–1785, 1971Google Scholar
  2. 2.
    Shapiro S, Venet W, Strax P et al.: Periodic screening for breast cancer: The health insurance plan project and its sequelae, 1963–1986. John Hopkins University Press, Baltimore, 1988Google Scholar
  3. 3.
    Lundgren B: Population screening for breast cancer by single view mammography in a geographic region in Sweden. J Natl Cancer Inst 62: 1373–1379, 1979Google Scholar
  4. 4.
    Tabár L, Fagerberg C, Gad A et al.: Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1: 829–832, 1985Google Scholar
  5. 5.
    Andersson I, Aspegren K, Janzon L et al.: Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 297: 943–948, 1988Google Scholar
  6. 6.
    Nyström L, Rutqvist LE, Wall S et al.: Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1:341: 973–978, 1993Google Scholar
  7. 7.
    Frisell J, Eklund G, Helström L et al.: Randomized study of mammographic screening — preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18: 49–56, 1991Google Scholar
  8. 8.
    Shapiro S, Venet W, Strax P et al.: Ten-to fourteen year effect of screening on breast cancer mortality. J Natl Cancer Inst 62: 349–355, 1982Google Scholar
  9. 9.
    Miller AB, Baines C, To T, Wall C: Canadian National Breast Screening Study: I. Breast cancer detection and death rates among women aged 40–49 years. Can Med Assoc J 147: 1459–1498, 1992Google Scholar
  10. 10.
    Falun meeting on breast cancer screening with mammography in women aged 40–49 years: report of the organising committe and collaborators. In press. Intern J Cancer 1996Google Scholar
  11. 11.
    Frisell J, Glass U, Hellström L, Somell A: Randomized mammographic screening for breast cancer in Stockholm. Breast Cancer Res Treat 8: 45–54, 1986Google Scholar
  12. 12.
    Frisell J, Eklund G, Odont D, Hellström L, Glas U, Somell A: The Stockholm breast cancer screening trial — 5-year results and stage at discovery. Breast Cancer Res Treat 13: 79–87, 1988Google Scholar
  13. 13.
    Lidbrink E, Elfving J, Frisell J, Jonsson E: Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial. BMJ 312: 273–276, 1995Google Scholar
  14. 14.
    Lidbrink E, Levi L, Pettersson I, Rosendahl I, Rutqvist LE, de la Torre B, Wasserman J, Wiege M: Single-view screening mammography: psychological, endocrine and immunological effects of recalling for a complete three-view examination. Eur J Cancer 31A,No 6: 932–933, 1995Google Scholar
  15. 15.
    Tabár L, Gad A: Screening for breast cancer: The Swedish trial. Radiol 138: 219–222, 1981Google Scholar
  16. 16.
    Frisell J, von Rosen A, Wiege M, Nilsson B, Goldman S: Interval cancer and survival in a randomized breast cancer trial in Stockholm. Breast Cancer Res Treat 24: 11–16, 1992Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • Jan Frisell
    • 1
  • Elisabet Lidbrink
    • 1
  • Lars Hellström
    • 2
  • Lars-Erik Rutqvist
    • 2
  1. 1.Departments of Surgery, Oncology and RadiologySödersjukhuset
  2. 2.Oncologic Centre, RadiumhemmetKarolinska HospitalStockholmSweden

Personalised recommendations